Vertex Pharmaceuticals Other Operating Income or Expenses 2010-2024 | VRTX
Vertex Pharmaceuticals other operating income or expenses for the twelve months ending December 31, 2024 were $0M, a 99.03% decline year-over-year.
- Vertex Pharmaceuticals annual other operating income or expenses for 2024 were $0.001B, a 99.03% decline from 2023.
- Vertex Pharmaceuticals annual other operating income or expenses for 2023 were $0.052B, a 10.26% decline from 2022.
- Vertex Pharmaceuticals annual other operating income or expenses for 2022 were $0.058B, a 1754.84% increase from 2021.